Search - tctmd.com

Displaying 121 - 140 of 396

Sort: Relevancy | Date

News Daily News

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Yael L. Maxwell

March 03, 2021

News Daily News

Long-term CTO Data Raise Questions Over Primary Goals of Care

Yael L. Maxwell

February 08, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Daily News

Stroke After PCI, CABG Signals Higher Long-term Mortality in Modern Era

Todd Neale

December 08, 2020

News Conference News AHA 2020

When PCI Decisions Ignore FFR Results, Patients Pay a Price

Caitlin E. Cox

November 14, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Michael O'Riordan

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

Presenter: Mahmoud Barbarawi

October 14, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

Todd Neale

September 22, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

Advertisement

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Long-term CTO Data Raise Questions Over Primary Goals of Care

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Review Spotlights SCAD Diagnosis and Treatment

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Stroke After PCI, CABG Signals Higher Long-term Mortality in Modern Era

When PCI Decisions Ignore FFR Results, Patients Pay a Price

November 2020 News Roundup

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

FFR Insights Before and After PCI: Fresh Food for Thought

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content